596TiP Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours. - Powderly, J.; Shimizu, T.; Lorusso, P.; Razak, A.; Miller, K.D.; Balar, A.V.; Bruix, J.; Michel, L.S.; Blaney, M.; Guan, X.; Lacy, S.; Lally, S.; et al. (Annals of Oncology, 2020)